TYLER, Texas NanoVibronix, Inc. (NASDAQ: NAOV), a pioneering medical device company known for its Surface Acoustic Wave (SAW) Portable Ultrasonic Therapeutic Devices, namely UroShield, PainShield, and WoundShield, has recently issued a comprehensive letter to its stockholders. This communication, delivered by Chief Executive Officer Brian Murphy, provides a detailed review of the company s performance during the first quarter of 2024 and outlines the key business developments that have occurred since the beginning of the year. To Our Stockholders, We remain steadfast in our commitment to fostering a strategic vision that revolves around the development, refinement, and successful commercialization of our g...
NanoVibronix, a leading medical device company specializing in ultrasonic therapeutic devices, has recently announced that its PainShield product will be included in the U.S. Department of Veteran Affairs (VA) Federal Supply Schedule (FSS) starting May 1, 2024. This significant milestone allows the Company to support the healthcare acquisition needs of the VA, further positioning itself as a provider of innovative solutions for pain management. In a letter to shareholders, NanoVibronix s Chief Executive Officer, Brian Murphy, provided an overview of the third quarter of 2023 and highlighted recent business developments.NanoVibronix s PainShield product, a Surface Acoustic Wave (SAW) Portable Ultrasonic Thera...
NanoVibronix, a leading medical device company specializing in Surface Acoustic Wave (SAW) Portable Ultrasonic Therapeutic Devices, recently released its third-quarter 2023 update along with key business developments. In a letter to shareholders, CEO Brian Murphy highlighted the company s commitment to advancing innovation, improving existing products, and expanding commercialization efforts. This article will delve into the details of NanoVibronix s progress and explore the exciting prospects the company holds within the medical device industry. Review of Third Quarter 2023: NanoVibronix s third quarter proved to be a period of notable achievements. The company experienced robust growth ac...
(Revenue and Income for Trailing 12 Months, in Millions of $, except Employees)
COMPANY NAME
MARKET CAP
REVENUES
INCOME
EMPLOYEES
0.00
0.00
0.00
-
SUBTOTAL
0.00
0.00
0.00
-
Sources:
’s official press releases and regulatory filings; CSIMarket.com’s market research; and the financial filings and press releases of other companies cited in this report.
Updated on:
Focus of this report: ’s corporate clients.
For your research, we’ve provided 9 tables on corporate clients.
You can find them in the navigation menu under Customers & Markets.
To download the tables, please subscribe.
100 %